Elevated levels of CCL19 in CSF in MS patients have also been shown to correlate with elevated levels of intrathecal IgG production [100], suggesting that CCR7 also plays a role in the differentiation and expansion of IgG-producing B cells in MS (Figure 4). Here, CCL19 is linked to myeloid sarcoma.